UA98665C2 - Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения - Google Patents

Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения

Info

Publication number
UA98665C2
UA98665C2 UAA201003470A UAA201003470A UA98665C2 UA 98665 C2 UA98665 C2 UA 98665C2 UA A201003470 A UAA201003470 A UA A201003470A UA A201003470 A UAA201003470 A UA A201003470A UA 98665 C2 UA98665 C2 UA 98665C2
Authority
UA
Ukraine
Prior art keywords
medicinal preparation
treatment method
malignant cells
action against
against malignant
Prior art date
Application number
UAA201003470A
Other languages
English (en)
Ukrainian (uk)
Inventor
Геннадий Васильевич Мазильников
Аркадий Петрович Шиманский
Юрий Анатольевич Лиходед
Стефания Стефановна Мельник
Original Assignee
Геннадий Васильевич Мазильников
Аркадий Петрович Шиманский
Лиходид Юрий Анатольевич
Стефания Стефановна Мельник
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Геннадий Васильевич Мазильников, Аркадий Петрович Шиманский, Лиходид Юрий Анатольевич, Стефания Стефановна Мельник filed Critical Геннадий Васильевич Мазильников
Priority to UAA201003470A priority Critical patent/UA98665C2/ru
Priority to PCT/UA2010/000014 priority patent/WO2011119125A1/ru
Publication of UA98665C2 publication Critical patent/UA98665C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к медицине, в частности к онкологии, касается лекарственного препарата, содержащего оксалат лития, диметилксантин и фторурацил, и способа лечения злокачественных опухолей.
UAA201003470A 2010-03-25 2010-03-25 Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения UA98665C2 (ru)

Priority Applications (2)

Application Number Priority Date Filing Date Title
UAA201003470A UA98665C2 (ru) 2010-03-25 2010-03-25 Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения
PCT/UA2010/000014 WO2011119125A1 (ru) 2010-03-25 2010-03-26 Применение оксалата лития в производстве лечебного препарата противоопухолевого действия по отношению к злокачественным клеткам, лечебный препарат на его основе и способ лечения

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201003470A UA98665C2 (ru) 2010-03-25 2010-03-25 Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения

Publications (1)

Publication Number Publication Date
UA98665C2 true UA98665C2 (ru) 2012-06-11

Family

ID=44673472

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201003470A UA98665C2 (ru) 2010-03-25 2010-03-25 Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения

Country Status (2)

Country Link
UA (1) UA98665C2 (ru)
WO (1) WO2011119125A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013074055A1 (ru) * 2011-11-16 2013-05-23 ШИМАНСКИЙ, Аркадий Петрович Способ оздоровления и омоложения организма человека и фармацевтическая композиция для его осуществления

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133317A (en) * 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate composition and method of treatment
AU2003270202A1 (en) * 2002-09-17 2004-04-08 Centre National De La Recherche Scientifique Pharmaceutical compositions increasing camp useful for the treatment of cancers
KR100881043B1 (ko) * 2004-06-03 2009-01-30 에프. 호프만-라 로슈 아게 옥살리플라틴 및 egfr­억제제로의 치료
JP2008507499A (ja) * 2004-07-23 2008-03-13 オーエム ファルマ 併用抗癌療法とその医薬組成物
CN101657203B (zh) * 2007-03-02 2012-09-05 卧龙岗大学 抗癌药的组合物及递送方法

Also Published As

Publication number Publication date
WO2011119125A1 (ru) 2011-09-29

Similar Documents

Publication Publication Date Title
GB201106750D0 (en) Novel compounds
GB201106743D0 (en) Novel compounds
LT2807159T (lt) Nauji indolizino junginiai, jų gamybos būdai ir juos turinčios farmacinės kompozicijos, skirtos vėžio gydymui
PH12013500955A1 (en) Spiro-oxindole mdm2 antagonists
GEP20186816B (en) Anty il-36r antybodies
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
MX366804B (es) Translocaciones de la r-espondina y sus metodos de uso.
EP2563426A4 (en) APPLICATION WITH HIGH SCAM FOR MEDICAL THERAPY
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
IL207310A0 (en) Vaccine compositions
GB201316021D0 (en) Vitamin D composition
PH12015501088A1 (en) Dimeric compounds
MX359210B (es) Composición de combinación de pac-1 y tamoxifeno.
IN2014MN01944A (ru)
NZ707636A (en) Ingenol-derived compounds that can be used for treating cancer
WO2014083019A3 (en) Agent for modulating the dissemination of cancer cells, product comprising said agent, and use of said agent in the treatment and/or prevention of cancer
MX2013010947A (es) Complejos de galio, composiciones farmacéuticas y métodos de uso.
WO2012173677A3 (en) Anticancer therapeutic agents
UA98665C2 (ru) Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения
UA98666C2 (ru) Лекарственный препарат на основе щавелевой кислоты, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения
MX2013012551A (es) Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares.
MX350868B (es) Medicamentos y metodos para tratar cancer.
GB2519004A (en) Quinone compounds and their uses for the treatment of cancer
UA46888U (ru) Способ лечения местнораспространенных форм рака молочной железы
UA60887U (ru) Способ комплексного лечения местно-распространенного рака молочной железы